UPDATE: Valeant Posts Upbeat Q4 Profit

Valeant Pharmaceuticals International (NYSE: VRX ) posted a profit in the fourth quarter. Valeant posted its quarterly net income of $123.8 million, or $0.36 per share, versus a year-ago loss of $89.1 million, or $0.29 per share. Excluding one-time items, it earned $2.15 per share. Its revenue jumped to $2.06